Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation

Biochemical Pharmacology

Volumn 62, Issue 12, 2001, Pages 1637-1645

  Ferri, Nicola ^a   Arnaboldi, Lorenzo ^a   Orlandi, Augusto ^b   Yokoyama, Kohei ^c   Gree, Renè ^d   Granata, Agnese ^a   Hachem, Ali ^d   Paoletti, Rodolfo ^a   Gelb, Michael H ^c   Corsini, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIV RENNES   (France)

Author keywords

Atherosclerosis; Farnesol; Farnesyltransferase inhibitors; Geranylgeraniol; Geranylgeranyltransferase inhibitors; Isoprenoids

Indexed keywords

DODECYL SULFATE; FARNESOL; GERANYLGERANIOL; MEVALONIC ACID; PERILLIC ACID; PROTEIN;

ANIMAL CELL; AORTA MEDIA; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LYSATE; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOARCHITECTURE; DENSITOMETRY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HEART PROTECTION; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRENYLATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CYCLOHEXENES; DNA; MALE; MEVALONIC ACID; MONOTERPENES; MUSCLE, SMOOTH, VASCULAR; PROTEIN ISOPRENYLATION; RATS; RATS, SPRAGUE-DAWLEY; TERPENES;

EID: 0035894057     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00808-5     Document Type: Article

References (44)

1. Atherosclerosis: An inflammatory disease
2. Regulation of the mevalonate pathway
3. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes
4. Relationship between mevalonate pathway and arterial myocyte proliferation: In vitro studies with inhibitors of HMG-CoA reductase
5. Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation
6. Specific labeling of isoprenylated proteins: Application to study inhibitors of the post-translational farnesylation and geranylgeranylation
7. Incorporation of radiolabeled prenyl alcohols and their analogs into mammalian cell proteins. A useful tool for studying protein prenylation
8. Recent advances in the study of prenylated proteins
9. Purification of a mammalian protein geranylgeranyltransferase. Formation and catalytic properties of an enzyme-geranylgeranyl pyrophosphate complex
10. Protein prenyltransferases
11. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells
12. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I
13. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells
14. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol
15. Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells
16. Inhibition of protein prenylation by metabolites of limonene
17. Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites
18. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation
19. Prenylated proteins and lymphocyte proliferation: Inhibition by d-limonene related monoterpenes
20. PA inhibits Ras/MAP kinase-driven IL-2 production in human T lymphocytes
21. Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition
22. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation
23. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth
24. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene
25. Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day
26. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent to the dog
27. Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes
28. A new route to 8- and 9-Substituted Carenes
29. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype
30. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits
31. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines
32. Cell cycle-specific effects of lovastatin
33. A farnesyl-protein transferase inhibitor induces p21 expression and G1 block in p53 wild type tumor cells
34. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells
35. 3-Hydroxy-3-methylglutaryl coenzyme a reductase, and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
36. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells
37. Perillyl alcohol, an inhibitor of geranylgeranyl transferase, induces apoptosis of immortalized human vascular smooth muscle cells in vitro
38. Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: Implications in chemical atherogenesis
39. G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. 1. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-gamma subunits and p21ras
40. Effect of statin therapy on restenosis after coronary stent implantation
41. Inhibition of hepatic cholesterol synthesis and S-3-hydroxy-3- methylglutaryl-CoA reductase by mono and bicyclic monoterpenes administered in vivo
42. Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol
43. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors
44. Identifying differential gene expression in monoterpene-treated mammary carcinomas using subtractive display